RESUMEN
Chronic wounds present a high risk of infection due to delayed and incomplete healing, leading to increased health risks and financial burden to health-care systems. Numerous approaches to promote wound healing have been extensively explored, especially the development of effective wound dressing materials embedded with therapeutic drug molecules. Despite advances made in this area, a remaining challenge to be addressed is the controlled, on-demand release of therapeutic molecules using noncytotoxic stimulus, for example, near-infrared (NIR) excitation. Here, we report a platform that allows for the development of electrospun poly(vinyl alcohol) (PVA) fibrous hybrids embedded with upconverting nanoparticles (UCNPs) and UV-cleavable levofloxacin conjugates for wound dressings. Upon irradiation with NIR light, the excited UCNPs emit UV light around 365 nm, which can cleave the o-nitrobenzyl (ONB) linkage of the levofloxacin conjugates in the PVA fiber, leading to controlled drug release. The release was observed to be triggered only under NIR and UV irradiation, with no effect in the dark. Furthermore, the antibacterial effect against Escherichia coli and Staphylococcus aureus was successfully demonstrated, highlighting the versatility of the electrospun upconverting fiber platform. The development of antibacterial fibrous meshes with on-demand release of encapsulated drugs is imperative for precise treatment of wound infections.
